Crescita Therapeutics (TSE:CTX) Shares Down 2.1% – Here’s Why

Crescita Therapeutics Inc. (TSE:CTX)’s share price traded down 2.1% during trading on Thursday . The stock traded as low as C$0.47 and last traded at C$0.47. 4,000 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 35,187 shares. The stock had previously closed at C$0.48.

Crescita Therapeutics Stock Performance

The company has a current ratio of 3.12, a quick ratio of 2.29 and a debt-to-equity ratio of 2.98. The stock’s 50 day moving average is C$0.48 and its 200 day moving average is C$0.47. The stock has a market capitalization of C$8.66 million, a price-to-earnings ratio of 23.25 and a beta of -0.39.

About Crescita Therapeutics

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.